Position in TRLV
as of Sep 30, 2026
· filed Oct 2, 2026
Position Value
$29,342
New position
Shares Held
2,692
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 4 holders
Holding Since
Sep 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Sep 30, 2026CX Institutional holds $569,212 across 7 Drug Manufacturers - Specialty & Generic names. TRLV ranks #4 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
19,738 | $349,757 | |
| 2 | ZTS |
Zoetis Inc.
|
1,697 | $118,501 | |
| 3 | GLAS |
Glass House Brands Inc.
|
5,275 | $29,592 | |
| 4 | TRLV |
Trulieve Cannabis Corp.
This page
|
2,692 | $29,342 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
126 | $17,871 | |
| 6 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
573 | $14,789 | |
| 7 | HLN |
Haleon plc
|
1,040 | $9,360 |
All Filings in TRLV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-09-30 | $29,342 | 2,692 | Shares | Sole | 2026-10-02 | |
| No filing history on record for this holder in this stock. | ||||||